#ICYMI: Gayle Benson, a favorite Saint, will invest $50 million in Gulf South startups with a new venture fund. A touchdown for economic growth and small business owners in our region. nola.com/news/article_f…

Flurry of Regulatory Activity Driven by COVID-19 Anxiety Impacts Health Plan Requirements and Permissible Actions - C&M #HealthLaw CVSoci.al/7m1rfOfy

New blog post: Molecular Diagnostics: A Broken Business Model or Flawed Execution? link.medium.com/xuPijvAzI5 #cancer #cancertherapymonitoring #diagnostics

"...Diagnostics have been really taken for granted Its been viewed as a commodity for the industry, an afterthought. It isn’t valued properly in the whole healthcare continuum. It isn’t paid for properly. I think that’s changing now..." medcitynews.com/2020/05/sectio…

Happy to have contributed data to this important whitepaper.

Genetic testing for cancer, therapy monitoring, and recurrence - a +$50B addressable market. investors.com/news/technolog…

Cadex Genomics founders Bill Haack and Greg Schafer talk about real-time cancer therapy monitoring on the MedTech Trends podcast. youtube.com/watch?v=4lvStF…

Congratulations to the team AxoSim.

Our next #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us on April 12 as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: bit.ly/3DF8ZiK #AngelMD

One of our guest speakers on our next #PitchClub is Bill Haack, CEO of Cadex Genomics. Join us with him on April 12 as we discuss more on #Innovation in #Biotech, #Lab and #Precision medicine. Register via this link: bit.ly/3DF8ZiK #AngelMD

Today's #PitchClub revolves around #innovation in #Biotech, #Lab and #Precision medicine. Join us at 6PM MT as we have a discussion with our member startups, #healthcare experts, and innovators. To sign up, click here: bit.ly/3DF8ZiK

#PitchClub starts at 6PM MT. Hear from Cadex Genomics & scriptchain health. #startups #physicians #familyoffice #venturecapital #free bit.ly/3DF8ZiK

youtu.be/sEcH14v0jmQ

Bill & the Cadex Genomics team are tackling an incredibly important part of the fight against Stage IV cancers.

Please join Cadex Genomics and AngelMD Capital at a webinar on Wednesday, August 17th to learn more about real-time therapy monitoring for cancer patients. Save your seat: docs.google.com/forms/d/e/1FAI…

We're excited to have a new channel with which to showcase the entrepreneurs, physicians, dentists, investors & Industry stakeholders advancing healthcare innovation day in and day out.

At Cadex Genomics, we are interrogating a late-stage cancer patient's blood to determine if a tumor is growing early in a line of therapy and identify non-effective therapy in 12-21 days after starting a cycle of therapy versus waiting 8-12 weeks. issuu.com/mdnext/docs/md…